
Tinea
Typical appearance: Annular/scaly lesion with well-defined edge, central clearing, ± pruritus/inflammation
Clinical Presentations
Tinea pedis (feet) – Most common in adults
Maceration in toe webs, vesicles, or diffuse sole scaling
Often coexists with tinea cruris or onychomycosis
Tinea cruris (groin) – Common in males
Well-demarcated erythematous rash in groin ± upper thighs/buttocks
Tinea corporis (trunk, limbs, face) – "Ringworm"
Annular, itchy lesions; more inflammatory if animal-derived
Tinea manus (hands) – Unilateral scaling of palms or ring-shaped lesions on dorsum
Tinea capitis (scalp) – Children
Patchy hair loss, scaling, black dot sign (broken hairs)
Kerion: Painful, pustular boggy mass (severe inflammatory variant)
Onychomycosis (nails) – Requires separate management
Thickened, brittle, discoloured nails
Differential Diagnoses
Eczema (dermatitis): Tinea has sharper border, central clearing
Pityriasis rosea: Herald patch, follows skin cleavage lines
Granuloma annulare: Ring-like but lacks scale/itch
Psoriasis: Thicker scale, nail pitting, less annular
Candidiasis: In moist skin folds, lacks true ring pattern
Diagnosis
Clinical suspicion: Annular scaly lesion ± itch
Microscopy & culture (for confirmation before oral therapy)
Skin scrapings, nail clippings, plucked hairs
Wood lamp (fluoresces Microsporum canis)
Indications for Topical vs. Oral Therapy
Topical therapy: Recent onset, localised (trunk, groin, limbs, interdigital)
Oral therapy: Widespread, hyperkeratotic, recurrent, scalp/palm/sole involvement, treatment failure
Management
Topical Therapy (Mild, Localised Infections)
Terbinafine 1% cream/gel: Once/twice daily 1–2 weeks (preferred)
Azoles (clotrimazole, ketoconazole, miconazole, bifonazole, econazole): Once/twice daily 2–4 weeks
Key Points:
Avoid steroid-antifungal combinations (does not improve cure rates)
Keep feet dry, change socks, dry shoes thoroughly
If no improvement → reassess diagnosis or consider oral therapy
Oral Therapy (Extensive, Resistant, Hyperkeratotic, Palms/Soles, Recurrent Cases)
Terbinafine 250 mg daily (adults)
2 weeks (corporis/cruris), 4 weeks (pedis)
Children: <20 kg → 62.5 mg, 20–40 kg → 125 mg
Fluconazole 150 mg weekly (6 weeks)
Itraconazole (Sporanox)
100 mg daily (corporis/cruris 2 weeks, pedis 4 weeks)
Lozanoc capsule: 50 mg daily (same duration)
Griseofulvin 500 mg daily (cheaper, less effective)
Child: 10 mg/kg (max 500 mg) 8–12 weeks
Tinea Capitis (Scalp) – Always Requires Oral Therapy
Terbinafine 250 mg daily x 4 weeks (Trichophyton)
Children: Dose by weight
Griseofulvin 20 mg/kg daily x 6–8 weeks (Microsporum)
Alternatives:
Itraconazole (Sporanox liquid) 5 mg/kg daily x 4 weeks
Fluconazole 6 mg/kg daily (3–6 weeks) OR 8 mg/kg weekly (8–12 weeks)
Kerion (Severe Inflammatory Tinea Capitis)
Urgent referral
Treat with oral antifungals ± antibiotics (secondary infection)
Follow-Up
Repeat culture at end of treatment
If scalp clinically normal + negative culture → stop therapy
Persistent positive culture → continue treatment, reassess every 4–6 weeks
Bookmark Failed!
Bookmark Saved!